The startup investor directory
Hawke Ventures, a VC firm established in Los Angeles, California, funds nascent-stage tech companies geared toward commerce enablement, MarTech and AdTech. Moreover, group invests between $50k and $2M in seed and early-phase companies, and has a portfolio of over 50 companies. Hawke Ventures also has an extensive network of co-investors, which includes investors from top startup capital firms and corporations. Notably, group is led by seasoned founders who provide mentorship and resources to their partner companies.
Pre-seed hard-tech program that co-builds physical prototypes with in-house engineers/designers, presents a 35,000 sq ft Newark lab plus Shenzhen/Pune manufacturing teams, and mixes cash with in-kind engineering services. With a disciplined investment approach, the team drives value for both founders and investors.
Operates as a small core fund plus heavy AngelList syndicates, hunting high-signal founders across geographies and categories, with craftsman mentality and systematic visibility into large multi-stage platforms' decisions. The firm continues to build its presence across the venture capital landscape.
Hardtech investor paired with a selective 500+ community (<7% acceptance) providing shared manufacturing, distribution and supply‑chain resources, ~200 partners (Foxconn, Amazon Launchpad) and motorsport engineering from Cyril Abiteboul. The firm continues to build its presence across the venture capital landscape.
Early-phase investor with autonomous regional teams in US, Europe, Brazil/LatAm and Asia using a proprietary tech OS tracking 10M+ startup ventures, 10+ years of data to underwrite and globalize winners. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Heal Capital operates as an investment fund headquartered in Berlin, Germany launched in 2019. The group centers its expertise in investments in healthcare and tech-driven nascent-stage companies, and is backed by 25+ German private health insurance companies. Additionally, fund aims to make investments that improve healthcare and the lives of patients by investing in the next generation of innovators and digital health companies. It also works with major corporations to advise them on what matters in digital health.
Invests pre-seed–Series A with $100K–$500K checks, focusing exclusively on health-equity solutions for diverse, underserved populations and serving as an institutional on-ramp for overlooked founders. With a disciplined investment approach, the team drives value for both founders and investors.
Hands-on formative-stage life‑science investor and advisor delivering deep, science-driven due diligence (PoC, MoA, animal models, KOL/clinician interviews) and access to pharma, corporate partnerships and stakeholder networks. With a disciplined investment approach, the team drives value for both founders and investors.
Women-led fund centered on healthcare infrastructure—middleware, payments, clinical trials, and data architecture—thesis-driven, GTM-heavy partner providing hands-on commercialization support for technical founders scaling into payer and provider markets. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Corporate venture arm giving founders direct access to 360+ Hearst operating businesses for distribution, plus a 220+ women-executive Scout network that advises during diligence and as operating advisors. The firm continues to build its presence across the venture capital landscape.
Positioned as a software development company, HeartCore prioritizes creating cutting-edge solutions for businesses. Launched in 2007, the organization is dedicated to developing custom software, building digital products, and creating digital experiences. HeartCore has a team of seasoned software developers who are dedicated to delivering solutions that are reliable, secure, and easy to use. The organization additionally extends consulting services, empowering clients to identify and develop the best software solutions for their business needs. HeartCore remains dedicated to creating solutions that are tailored to the unique needs of each client, coupled with delivering ongoing support to ensure the strong outcomes of the solutions.
Early-phase investor in enterprise infrastructure that works hands-on from day 0 to assistance technical founders turn code into companies across DevSecOps, feature flagging and AI code generation. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Helicase Venture operates as a venture fund operating from Boston, Massachusetts and established in 2018. The fund directs capital toward life science and healthcare companies, with a preference for early-phase companies with cutting-edge technologies and approaches. Their investment activities span across a broad spectrum of areas, including diagnostics, therapeutics, medical devices, and digital health. They strive to empower business builders and to provide their portfolio ventures with the resources and insights needed to prosper.
Permanent, flexible single-family-office co-investor centered on frontier/new-space and adjacent deeptech, providing lean, hands-on partnership, top investor syndicate access, and philanthropic-to-institutional space ecosystem connectivity via founder Ryan Kriser. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Operating as a single family office that oversees over 1 billion dollars in diversified assets, Hellens Rock stands out in its space. Its venture capital arm concentrates on healthcare, fintech, blockchain, and other technology startups, and delivers its stakeholders with access to capital, assets, and ecosystems. Hellens Rock also has a license analysis framework that empowers companies identify compliance risks and automate the license analysis for Oracle DB. Furthermore, they have recently introduced a framework called IKrezi that delivers users with a full overview of their activities. Hellens Rock is led by Sacha Dragic and has received investments from multiple institutions and investors, encompassing Fortech Investments, Spotlight, and Hellen's Rock Capital.
Henkel Ventures, a venture capital firm that deploys capital in early- to mid-stage companies in the consumer goods and technology sectors, continues to make its mark. Founded by Henkel AG & Co. KGaA in 2020, the firm is headquartered in D\u00fcsseldorf, Germany and concentrates its investments on companies located in Europe, the United States, and Asia. Henkel Ventures presents its roster companies access to Henkel's global ecosystem, expertise, and assets. The firm generally deploys capital in companies with a focus on the consumer packaged goods, health, beauty, and personal care industries, as well as the digital space.
Seed-stage VC of ex-engineers geared toward infrastructure software, delivering founders technical empathy, a 120–150 senior data/AI/infrastructure executive network for validation and early sales, and a data-driven, optimized deal funnel. With a disciplined investment approach, the team drives value for both founders and investors.
HG Ventures, a startup capital arm of The Heritage Group operating from Indianapolis, Indiana. The fund directs capital toward companies that are creating pioneering technologies and products which have the potential to create long-term mutual benefit. HG Ventures' portfolio includes companies in various industries such as data analysis, battery energy storage, and software development. Additionally, HG Ventures' Managing Director, Kip A. Frey, has been recognized among the Top 50 Emerging VCs. The firm continues to build its presence across the venture capital landscape.
Hi Inov operates as a VC firm established in Lyon, France, launched in 2012. Furthermore, they invest in formative stage B2B digital emerging ventures. Moreover, team is an active player in local, European, and international networks, and they prioritize diversity, innovation, and dialogue between all stakeholders in the startup ecosystem. Hi Inov also concentrates on ESG criteria during their investment opportunity analysis, with a particular emphasis on energy consumption. With a disciplined investment approach, the team drives value for both founders and investors.
Operating as a venture studio, High Alpha is dedicated to empowering startup founders create and launch successful products. Beyond this, they partner with business builders to build software-driven businesses, leveraging their expertise in company-building to empower their partners bring their ideas to life. Notably, they have expertise in product design, marketing, finance, operations, and other areas of business, and they work with both early-phase emerging ventures and established companies looking to add new offerings. Their portfolio includes companies in a broad spectrum of industries, including healthcare, finance, consumer products, and more.
High Flyers Capital, a VC group headquartered in Paris, France. The organization seeks investments in the food and beverage sector, and has deployed capital into companies such as Bon Vivant, Stokelp, and STATION F. It has also provided funding to startup ventures in other sectors, such as Join Capital, Loveventures, and Super Nova. High Flyers Capital is driven to delivering value and resources to its invested companies, and works to create long-term relationships with them. The firm continues to build its presence across the venture capital landscape.
Seed-stage investor oriented toward tech ventures led by underrepresented founders, presenting a service-heavy, transparent model, dual DC/Little Rock presence to access noncoastal markets, and a structured domain-expert advisor bench. With a disciplined investment approach, the team drives value for both founders and investors.
Solo-GP Dr. Ling Wong (MIT, Harvard PhD; inventor of the first inhaled TB vaccine) invests $500K–$50M seed through growth, bringing scientific expertise, breakout-company established record and top-tier co-investor access. The firm continues to build its presence across the venture capital landscape.
Positioned as a venture studio and venture investment firm, Highline Beta supports big companies expand and develop forward-thinking products, services, and businesses. It works with Fortune 1000 companies to build new businesses and invest in early-phase companies, combining VC and corporate innovation expertise. Highline Beta extends access to capital, resources, and expertise to support companies achieve their goals, coupled with mentorship and support for founders. It also features portfolio management, growth planning, and risk management services.